Management of EGFR-Variant and ALK-Positive Non–Small Cell Lung Cancer Brain Metastasis

This clinical evidence synopsis summarizes the results of 3 multi-institutional cohort studies that compare tyrosine kinase inhibitors with or without stereotactic radiosurgery in patients with non–small cell lung cancer with brain metastases.